Industry Analysis & Industry Trends
Although the Cell Therapy industry is a fast-growing industry, its companies operate at a loss due to the high costs associated with research and development. Demand for the industry's products and services depends primarily on the level of investment in medical technology. Strong growth will slow slightly over the five years to 2020, but will still outpace a majority of the economy.... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Cell Therapy industry is in the growth phase of its economic life cycle. During the 10 years to 2020, IBISWorld estimates industry value added (IVA), a measure of the industry's contribution to the US economy, is expected to greatly outpace US GDP. IVA is projected to grow at an annualized 37.9% during this period, while IBISWorld forecasts US GDP to expand at an average annual 2.5% during the same period.
While some cell therapy has been around for decades, a rapid increase in research and development over the past decade has changed the industry's growth trajectory. The FDA approved no new products from 2002 to 2008 but half a dozen products have since been approved... purchase to read more